Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00884351 · ClinicalTrials.gov registry record

Magnetoencephalography in Absence Seizures

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
5
Enrollment target

NCT00884351: Completed study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00884351 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00884351 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
5 participants
Enrollment target

Study Summary

Background: * An absence seizure is a type of seizure that usually begins in childhood and goes away by early adulthood. Scientists do not yet know where absence seizures begin in the brain. Some evidence suggests that these seizures begin in the thalamus, a structure deep in the brain, but other studies suggest that they begin in the frontal cortex, at the front part of the brain. * Magnetoencephalography is a type of brain scanning procedure that is useful in determining information about what happens to the brain during epileptic seizures. Understanding where absence seizures come from may help doctors find new treatments for them. Objectives: * To gain a better understanding of which parts of the brain are affected in absence seizures. Eligibility: * Patients 7 to 35 years of age who have been diagnosed with absence seizures. Design: * Procedures are for research purposes only, not to diagnose or treat a particular medical condition. * Two outpatient visits to the National Institutes of Health Clinical Center: evaluation and scanning. * Researchers will evaluate potential participants with a medical history, physical examination, and electroencephalography (EEG). These tests will be performed under another protocol, 01-N-0139. * Patients will undergo magnetoencephalography (MEG) and magnetic resonance imaging (MRI) of the brain. The study procedures will be performed one time; however, an MEG or MRI scan may need to be repeated for technical reasons. Researchers will not do more than two MEG or MRI scans. * The MEG will record very small magnetic field changes produced by the activity of the brain. An EEG will be recorded at the same time as the MEG. * The MRI will use a magnetic field to take pictures of the inside of the brain. * The MEG will take 3 hours to complete (2 hours for preparation, 1 hour in the scanner). The MRI will take approximately 1 hour.

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2009-04-15
Est. Completion 2011-06-15

What the finished NCT00884351 record still lists

NCT00884351 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00884351 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00884351 about?

NCT00884351 is a clinical study titled "Magnetoencephalography in Absence Seizures". Background: * An absence seizure is a type of seizure that usually begins in childhood and goes away by early adulthood. Scientists do not yet know where absence seizures begin in the brain. Some evidence suggests that these seizures begin in the thalamus, a structure deep in the brain, but other s...

What is the current status of trial NCT00884351?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2009-04-15. Estimated completion is 2011-06-15.

Who is sponsoring clinical trial NCT00884351?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00884351, the US trial registry maintained by the National Library of Medicine. NCT00884351 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.